Impact of Oleoresin Capsicum Spray on Respiratory Function in Human Subjects in the Sitting and Prone Maximal Restraint Positions, Final Report

• NCJ Number: 182433
• Author(s): Theodore C. Chan M.D.; Gary M. Vilke M.D.; Jack Clausen M.D.; Richard Clark M.D.; Paul Schmidt M.S.; Thomas Snowden; Tom Neuman M.D.
• Date Published: 2000
• Length: 68 pages
• Grant Number(s): 98-IJ-CX-0079
• Sponsoring Agency: National Institute of Justice (NIJ)
• Sale Source: National Institute of Justice/NCJRS
• Publication Format: Document
• Publication Type: Research (Applied/Empirical)
• Language: English
• Country: United States of America
• Note: Dataset may be archived by the NIJ Data Resources Program at the National Archive of Criminal Justice Data

Annotation

Oleoresin Capsicium (OC) spray has gained wide acceptance in law enforcement to subdue violent suspects in the field, but it is alleged to have been associated with a number of in-custody deaths in the media and concern has focused on respiratory effects of OC spray as playing a potential role in these deaths.

Abstract

To assess the safety of commercially available OC spray in use by law enforcement agencies nationwide, both OC spray and positional restraint in human subjects were examined to determine if OC exposure by itself or in combination with positional restraint resulted in any significant respiratory compromise as measured by pulmonary function testing and assessment of oxygenation and ventilation. Study subjects performed four different experimental trials over two separate days in a pulmonary function testing laboratory in random order: placebo spray exposure followed by sitting position, placebo spray exposure followed by restraint position, OC spray exposure followed by sitting position, and OC spray exposure followed by restraint position. Prior to exposure, baseline spirometry measurements were obtained by pulmonary function testing. After exposure, repeat spirometric measurements were performed at 1.5 and 10 minutes. After a 1-hour rest, study subjects performed a second experimental trial. Completing the study were 34 individuals, 24 men and 10 women. No evidence was found that OC spray inhalation and exposure in human subject resulted in any respiratory compromise. Moreover, there was no evidence of hypoxemia or hypercapnia as a result of OC exposure. In fact, OC spray appeared to slightly increase ventilation. In the restraint position, declines were noted in pulmonary function typical for prone maximal restraint body position but no evidence was found of clinically significant spirometric abnormalities or differences between OC spray and placebo groups. The authors conclude that OC spray exposure and inhalation do not result in significant risk for respiratory compromise or asphyxiation. 61 endnotes and 8 exhibits